Tandem Diabetes (TNDM) Tops Q2 EPS by 2c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Join SI Premium – FREE
Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $254.6 million versus the consensus estimate of $254.93 million.
GUIDANCE:
Tandem Diabetes sees FY2026 revenue of $1.06-1.08 billion, versus the consensus of $1.08 billion.
For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Teledyne Technologies (TDY) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 EPS Guidance
- Alaska Air Group (ALK) Tops Q3 EPS by 8c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
